Elanco Animal Health Inc (ELAN) — 8-K Filings

8-K Filings (18)

• Elanco Animal Health Files 8-K on Exit Costs — Dec 9, 2025 Risk: medium
  Elanco Animal Health Incorporated filed an 8-K on December 9, 2025, reporting on cost associated with exit or disposal activities and Regulation FD disclosures
• Elanco Animal Health Files 8-K: Material Agreement & Financial Obligations — Nov 3, 2025 Risk: medium
  On October 31, 2025, Elanco Animal Health Incorporated entered into a material definitive agreement. This filing also indicates the creation of a direct financi
• Elanco Animal Health Enters Material Agreement — Jun 26, 2025 Risk: medium
  Elanco Animal Health Incorporated entered into a material definitive agreement on June 25, 2025. This filing also indicates the creation of a direct financial o
• Elanco Animal Health CFO Departs; Interim Appointed — May 28, 2025 Risk: medium
  Elanco Animal Health Incorporated announced on May 21, 2025, the departure of its Chief Financial Officer, Todd M. Young. The company has appointed Oliver G. Go
• Elanco Animal Health Files 8-K on Shareholder Votes — May 21, 2025 Risk: low
  Elanco Animal Health Incorporated filed an 8-K on May 21, 2025, reporting on matters submitted to a vote of security holders as of May 16, 2025. The filing deta
• Elanco Animal Health Inc. Announces Executive and Board Changes — Mar 17, 2025 Risk: medium
  Elanco Animal Health Incorporated announced on March 11, 2025, a significant event involving the departure of directors or certain officers, the election of new
• Elanco Animal Health Files 8-K — Jan 13, 2025 Risk: low
  Elanco Animal Health Incorporated filed an 8-K on January 13, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing detai
• Elanco Animal Health Announces Board and Executive Changes — Nov 12, 2024 Risk: medium
  Elanco Animal Health Incorporated announced on November 11, 2024, changes in its board of directors and executive compensation arrangements. The filing details
• Elanco Animal Health Files 8-K — Oct 16, 2024 Risk: low
  Elanco Animal Health Incorporated filed an 8-K on October 16, 2024, to report information under Regulation FD. The filing does not contain specific financial fi
• Elanco Animal Health Enters Material Definitive Agreement — Aug 13, 2024 Risk: medium
  Elanco Animal Health Inc. entered into a material definitive agreement on August 13, 2024, related to a financial obligation. The company, headquartered in Gree
• Elanco Completes Bayer Animal Health Acquisition — Jul 9, 2024 Risk: medium
  Elanco Animal Health Incorporated announced the completion of its acquisition of Bayer Animal Health on July 9, 2024. This strategic move is expected to signifi
• Elanco Animal Health Enters Material Definitive Agreement — Jul 3, 2024 Risk: medium
  Elanco Animal Health Inc. entered into a material definitive agreement on July 3, 2024, related to a direct financial obligation. The company, headquartered in
• Elanco Animal Health Announces Corporate Changes and Filings — Jun 4, 2024 Risk: medium
  Elanco Animal Health Incorporated announced on May 30, 2024, a series of significant corporate actions. These include the election of new directors, the appoint
• Elanco Appoints New Chief Legal Officer — Apr 1, 2024 Risk: low
  Elanco Animal Health Inc. announced on March 29, 2024, the appointment of Ms. Katharine P. (Kate) Nealon as Executive Vice President, Chief Legal Officer and Co
• Elanco Animal Health Files 8-K on Operations and Exit Costs — Feb 26, 2024 Risk: medium
  Elanco Animal Health Inc. filed an 8-K on February 22, 2024, reporting on its results of operations and financial condition, as well as costs associated with ex
• Elanco Files 8-K on Material Agreement & Reg FD Disclosure — Feb 5, 2024
  Elanco Animal Health Inc. filed an 8-K on February 5, 2024, to report an "Entry into a Material Definitive Agreement" and "Regulation FD Disclosure." While the
• Elanco Confirms NYSE Listing for Common Stock & Equity Units — Jan 8, 2024
  Elanco Animal Health Inc. filed an 8-K on January 8, 2024, to disclose that its Common Stock and 5.00% Tangible Equity Units are both registered on the New York
• Elanco Files Routine 8-K; Confirms Non-Emerging Growth Status — Jan 2, 2024
  Elanco Animal Health Incorporated filed an 8-K on January 2, 2024, primarily to disclose general corporate information and confirm its status as a non-emerging

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX